GO:0003105 negative regulation of glomerular filtration: Physiology, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003105 (negative regulation of glomerular filtration) describes any process that stops, prevents, or reduces the frequency, rate or extent of glomerular filtration, the blood-filtering step of the nephron.
• Glomerular filtration rate (GFR) is set by the balance of Starling forces across the glomerular capillary wall and by the surface area available for filtration, which is controlled by mesangial cell contraction and podocyte architecture.
• Mesangial cells are contractile pericytes that regulate the filtration surface area; their contraction reduces the ultrafiltration coefficient and therefore lowers GFR.
• Tubule-vascular feedback, including macula densa signaling and myogenic responses, provides moment-to-moment negative regulation of glomerular filtration and protects the glomerulus from barotrauma.
• Loss of negative regulation of glomerular filtration manifests clinically as hyperfiltration and microalbuminuria, early hallmarks of diabetic kidney disease and other nephropathies.
• Podocyte senescence and injury, driven by signaling such as GPR124 loss, impair the filtration barrier and are linked to diabetic kidney disease progression.
Description
Glomerular filtration is the process whereby blood is filtered by the glomerulus into the renal tubule, and its rate is one of the most tightly regulated variables in human physiology. GO:0003105, negative regulation of glomerular filtration, captures the biological processes that stop, prevent, or reduce the frequency, rate or extent of this filtration event. Because the glomerulus is a high-pressure capillary bed, unchecked filtration would damage the filtration barrier and cause proteinuria; negative regulation therefore protects both the filter and the downstream tubule. Researchers study GO:0003105 to understand how GFR is set in health, how it drifts upward in early diabetic kidney disease, and how it collapses in acute and chronic nephropathies. The term sits at the intersection of hemodynamics, contractile cell biology, and podocyte biology, making it a rich ontology node for both mechanistic and translational work.
negative regulation of glomerular filtration At A Glance
| GO ID | GO:0003105 |
|---|---|
| GO term | negative regulation of glomerular filtration |
| Ontology | biological_process |
| Synonym | none |
| Major function | Reduces or prevents the rate of blood filtration by the glomerulus into the renal tubule |
| Parent process | Regulation of glomerular filtration |
| Opposite process | Positive regulation of glomerular filtration |
| Key cell types | Mesangial cells, podocytes, afferent arteriolar smooth muscle, macula densa cells |
| Physiological readout | Reduced single-nephron and whole-kidney glomerular filtration rate (GFR) |
What Is GO:0003105?
In plain terms, GO:0003105 describes any biological process that lowers, prevents, or switches off glomerular filtration. The QuickGO definition states: any process that stops, prevents, or reduces the frequency, rate or extent of glomerular filtration, where glomerular filtration is the process whereby blood is filtered by the glomerulus into the renal tubule. Operationally, this includes vasoconstriction of afferent arterioles, mesangial cell contraction that reduces filtration surface area, changes in the ultrafiltration coefficient, and tubule-vascular feedback that adjusts single-nephron GFR. It is a biological_process term and has no synonyms in QuickGO.
Why Is negative regulation of glomerular filtration Important in Cell Biology?
Negative regulation of glomerular filtration is important because it protects the glomerular capillary wall from excessive hydraulic pressure and preserves the filtration barrier that retains plasma proteins. When this negative regulation fails, hyperfiltration and microalbuminuria appear, and these are among the earliest clinical signs of diabetic kidney disease and other progressive nephropathies. Understanding GO:0003105 therefore informs how clinicians interpret GFR, how researchers model early kidney disease, and how new therapies might restore protective vaso- and mesangial tone.
• Protects the glomerular filtration barrier from barotrauma caused by systemic and intraglomerular hypertension.
• Sets the ultrafiltration coefficient through mesangial cell contraction and relaxation.
• Provides tubule-vascular feedback that stabilizes single-nephron GFR.
• Prevents proteinuria by maintaining the size- and charge-selective barrier.
• Its failure produces hyperfiltration, an early feature of diabetic kidney disease.
• Links hemodynamic control to podocyte health and senescence.
• Is a pharmacological target for renin-angiotensin system blockade and other GFR-lowering strategies.
• Provides a conceptual framework for interpreting microalbuminuria screening.
• Connects kidney physiology to systemic conditions such as sepsis and critical illness.
• Guides experimental design for CRISPR models of kidney disease genes.
What Happens During negative regulation of glomerular filtration?
Afferent arteriolar tone and the myogenic response
In simple terms: The kidney's incoming blood vessel tightens when pressure rises, which lowers the pressure inside the filter.
The afferent arteriole responds to increased transmural pressure with myogenic constriction, a rapid intrinsic mechanism that reduces glomerular capillary pressure and therefore opposes filtration. This is one of the fastest negative regulators of glomerular filtration and operates independently of circulating hormones. By damping pressure transmission to the glomerulus, the myogenic response protects the delicate capillary endothelium and podocytes from mechanical injury.
Tubuloglomerular feedback from the macula densa
In simple terms: Cells in the tubule sense how much salt is arriving and signal back to the incoming vessel to adjust filtration.
The macula densa senses NaCl delivery in the distal tubule and, when delivery is high, triggers afferent arteriolar constriction that lowers single-nephron GFR. This tubule-vascular feedback is a classic negative feedback loop that stabilizes distal salt delivery and protects the glomerulus. It integrates tubular transport with vascular tone and is a core component of renal autoregulation.
Mesangial cell contraction and the ultrafiltration coefficient
In simple terms: Contractile cells inside the glomerulus squeeze the capillary loops, reducing the area available for filtering.
Mesangial cells are contractile cells that regulate the glomerular filtration surface area and thus the ultrafiltration coefficient (Kf). When they contract, Kf falls and GFR decreases; when they relax, Kf rises and GFR increases. This mechanism is particularly relevant in diabetic renal disease, where mesangial cell behavior is altered and contributes to changes in filtration rate.
Podocyte architecture and filtration barrier integrity
In simple terms: The specialized cells covering the filter must stay healthy and spread out, or the filter leaks and filtration control is lost.
Podocytes form the outer layer of the filtration barrier, and their foot processes and slit diaphragms are essential for selective filtration. Podocyte senescence and injury impair the barrier and are linked to diabetic kidney disease progression. Signaling through GPR124 has been shown to protect against podocyte senescence and injury, indicating that podocyte health is part of the machinery that maintains appropriate filtration.
Endothelial and glycocalyx contributions
In simple terms: The inner lining of the filter has a gel-like coat that helps hold back proteins and responds to flow.
The glomerular endothelium and its glycocalyx contribute to the barrier and to the sensing of shear stress, which in turn influences vascular tone. Although the QuickGO definition of GO:0003105 focuses on reducing filtration rate, endothelial and glycocalyx integrity are required for the barrier that negative regulation protects. Loss of this integrity is associated with albuminuria, a clinical sign that negative regulation has failed.
Key Genes Involved in GO:0003105 negative regulation of glomerular filtration
The genes and proteins below are experimentally linked to the control of glomerular filtration rate, mesangial and podocyte biology, or the tubule-vascular feedback that negatively regulates filtration.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GPR124 | Protects podocytes from senescence and injury | Studied in diabetic kidney disease models |
| AGT | Renin-angiotensin system precursor affecting vascular tone | Relevant to GFR-lowering pharmacology |
| REN | Renin, rate-limiting enzyme of angiotensin production | Central to hemodynamic control of filtration |
| ACE | Angiotensin-converting enzyme, generates angiotensin II | Target of GFR-modulating drugs |
| AGTR1 | Angiotensin II receptor type 1, mediates vasoconstriction | Key effector of negative regulation of GFR |
| NOS1 | Neuronal nitric oxide synthase in macula densa | Modulates tubuloglomerular feedback |
| NOS3 | Endothelial nitric oxide synthase | Regulates vascular tone and filtration |
| COX2 | Cyclooxygenase 2, prostaglandin synthesis | Influences afferent arteriolar tone |
| GSTK1 | Glutathione S-transferase kappa 1, reticulophagy regulator | Linked to tubular injury in diabetic nephropathy |
| RETREG1 | Reticulophagy receptor FAM134B | Attenuates tubular injury in diabetic nephropathy |
| NPHS1 | Nephrin, slit diaphragm protein | Podocyte barrier integrity |
| NPHS2 | Podocin, slit diaphragm protein | Podocyte barrier integrity |
| ACTN4 | Alpha-actinin-4, podocyte cytoskeleton | Podocyte architecture and filtration |
| MYH9 | Non-muscle myosin heavy chain, contractility | Mesangial and podocyte contraction |
| TRPC6 | Calcium-permeable channel in podocytes | Podocyte signaling and filtration |
| WT1 | Podocyte transcription factor | Podocyte identity and injury |
| VEGFA | Vascular endothelial growth factor A | Endothelial maintenance and filtration |
How Is negative regulation of glomerular filtration Regulated?
Negative regulation of glomerular filtration is itself regulated by multiple inputs. The renin-angiotensin-aldosterone system provides hormonal control of afferent and efferent arteriolar tone, and angiotensin II is a principal mediator of GFR reduction. Tubuloglomerular feedback adjusts afferent arteriolar resistance based on macula densa NaCl sensing, providing local negative feedback. Nitric oxide and prostaglandins modulate vascular smooth muscle tone and set the gain of these responses. In disease states such as diabetic kidney disease, mesangial cell behavior and podocyte health are altered, shifting the balance away from negative regulation and toward hyperfiltration. Podocyte-protective signaling, including GPR124-dependent pathways, also contributes to maintaining the filtration barrier that negative regulation defends.
negative regulation of glomerular filtration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPR124 | Diabetic kidney disease, podocyte senescence | Podocyte-specific knockout or overexpression in diabetic mouse models |
| AGT | Hypertension and GFR dysregulation | Renal overexpression or knockout models |
| GSTK1 | Diabetic nephropathy, tubular injury | Tubular-specific knockout with reticulophagy readouts |
| RETREG1 | Diabetic nephropathy, ER stress | Knockout or knock-in of reticulophagy receptor |
| NPHS1 | Proteinuric kidney disease | Podocyte-specific knockout or point mutation |
Diabetic kidney disease and hyperfiltration
Early diabetic kidney disease is characterized by hyperfiltration and microalbuminuria, reflecting a failure of negative regulation of glomerular filtration. Mesangial cell dysfunction and altered contractility contribute to changes in the ultrafiltration coefficient in diabetic renal disease. Transcriptomic profiling of early and advanced diabetic nephropathy has revealed new mechanisms of disease progression, including pathways that may influence filtration control. Podocyte senescence and injury, modulated by GPR124, are also implicated in diabetic kidney disease.
Microalbuminuria as a clinical readout
Microalbuminuria is an early clinical indicator of impaired glomerular filtration barrier function and is used to detect and monitor kidney disease. It reflects a state in which negative regulation of filtration and barrier integrity are insufficient. Because microalbuminuria is often reversible at early stages, understanding its mechanistic link to GO:0003105 has therapeutic implications.
Acute and critical illness
In critical illness, including sepsis, renal perfusion and glomerular filtration can be profoundly disturbed, and negative regulation of filtration may be overwhelmed. The 36th International Symposium on Intensive Care and Emergency Medicine highlighted the importance of understanding renal physiology in these settings. Although specific molecular mechanisms remain under study, the clinical relevance of GFR control in acute illness is well recognized.
Tubular injury and reticulophagy in nephropathy
GSTK1 and RETREG1/FAM134B-mediated reticulophagy attenuate tubular injury in diabetic nephropathy through endoplasmic reticulum stress and apoptosis pathways. While this primarily concerns tubular cells, tubular injury feeds back on glomerular function and is part of the broader nephropathy landscape in which filtration regulation is disrupted.
From negative regulation of glomerular filtration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce negative regulation of GFR? | Gene knockout in podocytes or mesangial cells |
| Does a specific variant alter podocyte barrier function? | Point-mutation knock-in in podocyte cell lines |
| Does tagging a protein reveal its localization in the glomerulus? | Tagged knock-in with fluorescent reporter |
| Does overexpression of a protective gene prevent hyperfiltration? | Overexpression in diabetic kidney disease models |
| Which genes mediate tubuloglomerular feedback? | Knockout of macula densa signaling genes |
| How does mesangial contractility affect ultrafiltration coefficient? | Primary mesangial cell contraction assays |
How to Study the negative regulation of glomerular filtration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Inulin clearance | Whole-kidney GFR | Gold-standard measurement in animal models |
| Micropuncture | Single-nephron GFR and pressures | Tubuloglomerular feedback studies |
| RNA-seq | Transcriptomic changes in kidney tissue | Diabetic nephropathy progression |
| Single-cell RNA-seq | Cell-type-specific gene expression | Podocyte and mesangial cell heterogeneity |
| Mesangial contraction assay | Ultrafiltration coefficient in vitro | Mesangial cell biology |
| Podocyte senescence assay | Senescence markers and injury | GPR124 signaling studies |
| Electron microscopy | Foot process and slit diaphragm structure | Filtration barrier integrity |
| Albuminuria measurement | Urinary albumin excretion | Clinical and preclinical kidney injury |
Measuring glomerular filtration rate in vivo
GFR is measured using clearance techniques such as inulin or iohexol clearance, or estimated from creatinine in clinical settings. In animal models, single-nephron GFR can be assessed by micropuncture or intravital imaging. These methods provide the physiological readout for negative regulation of glomerular filtration.
Transcriptomic and single-cell profiling
RNA sequencing of kidney biopsies has been used to compare early and advanced diabetic nephropathy and to reveal new mechanisms of disease progression. Single-cell and single-nucleus RNA-seq can resolve cell-type-specific changes in podocytes, mesangial cells, and tubular cells. These approaches help identify genes that may contribute to loss of negative regulation of filtration.
Podocyte and mesangial cell functional assays
Cultured podocytes and mesangial cells allow direct measurement of contractility, barrier function, and signaling. Mesangial cell contraction assays assess the ultrafiltration coefficient in vitro. Podocyte senescence and injury markers can be quantified to evaluate protective signaling such as GPR124.
Imaging of the glomerular filtration barrier
Electron microscopy and super-resolution imaging reveal podocyte foot process architecture and slit diaphragm integrity. Intravital multiphoton microscopy can visualize glomerular capillary dynamics and filtration in living animals. These methods link molecular changes to structural and functional outcomes.
How CRISPR Can Be Used to Study GO:0003105 negative regulation of glomerular filtration
Knockout
CRISPR knockout of candidate genes in podocytes or mesangial cells can test whether they are required for negative regulation of glomerular filtration. For example, knocking out GPR124 in podocytes would test its protective role against senescence and injury. Knockout models are also useful for genes implicated in tubuloglomerular feedback.
Point Mutation
Point-mutation knock-in can model specific variants in genes such as NPHS1 or ACTN4 that affect podocyte barrier function. These models help distinguish loss-of-function from dominant-negative effects. They are particularly valuable when a disease-associated variant is known.
Knock-in
Tagged knock-in of genes like NPHS1 or GPR124 allows visualization of protein localization and dynamics in the glomerulus. Knock-in of reporter cassettes can also be used to isolate specific cell types for downstream analysis. This approach links molecular identity to physiological function.
Overexpression
Overexpression of protective genes such as GPR124 in diabetic kidney disease models can test whether enhancing their activity restores negative regulation of filtration. Overexpression of renin-angiotensin system components can model hyperfiltration states. These experiments help identify therapeutic targets.
How EDITGENE Supports negative regulation of glomerular filtration Research
Researchers studying negative regulation of glomerular filtration-related genes often need to determine whether a candidate gene is causally involved in setting or protecting filtration rate. This requires precise, reproducible genetic models that can be interrogated with physiological and molecular readouts. EDITGENE provides the full suite of CRISPR cell model and screening services needed to move from candidate gene to mechanistic insight.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of glomerular filtration research.
Frequently Asked Questions About negative regulation of glomerular filtration
What is GO:0003105?
GO:0003105 is the Gene Ontology term for negative regulation of glomerular filtration, defined as any process that stops, prevents, or reduces the frequency, rate or extent of glomerular filtration.
What is negative regulation of glomerular filtration?
It is the biological process that lowers or prevents the filtration of blood by the glomerulus into the renal tubule, protecting the kidney from excessive filtration.
What genes are involved in negative regulation of glomerular filtration?
Genes involved include those controlling vascular tone (AGT, REN, ACE, AGTR1), mesangial contractility (MYH9), podocyte integrity (NPHS1, NPHS2, ACTN4, GPR124), and tubuloglomerular feedback (NOS1, COX2).
How is glomerular filtration negatively regulated?
It is negatively regulated by afferent arteriolar constriction, mesangial cell contraction, tubuloglomerular feedback, and maintenance of the podocyte filtration barrier.
What happens when negative regulation of glomerular filtration fails?
Failure leads to hyperfiltration and microalbuminuria, which are early signs of diabetic kidney disease and other nephropathies.
Which diseases are linked to impaired negative regulation of glomerular filtration?
Diabetic kidney disease, microalbuminuria, and acute kidney injury in critical illness are linked to impaired negative regulation of filtration.
How do mesangial cells reduce glomerular filtration?
Mesangial cells contract to reduce the glomerular filtration surface area and the ultrafiltration coefficient, thereby lowering GFR.
What is tubuloglomerular feedback?
It is a negative feedback mechanism in which the macula densa senses distal NaCl delivery and signals afferent arteriolar constriction to reduce single-nephron GFR.
Can CRISPR be used to study negative regulation of glomerular filtration?
Yes, CRISPR knockout, knock-in, and overexpression models in podocytes and mesangial cells can test the role of specific genes in filtration regulation.
What models are used to study negative regulation of glomerular filtration?
Common models include diabetic mouse models, podocyte and mesangial cell lines, and micropuncture or clearance measurements of GFR.
Conclusion
GO:0003105, negative regulation of glomerular filtration, is a physiologically essential process that protects the kidney from excessive filtration and protein loss. It is orchestrated by afferent arteriolar tone, mesangial cell contraction, tubuloglomerular feedback, and podocyte barrier integrity, with key roles for genes such as GPR124, NPHS1, and components of the renin-angiotensin system. Loss of this negative regulation underlies hyperfiltration and microalbuminuria in diabetic kidney disease and other nephropathies. Continued research using CRISPR models and multi-omic methods will clarify how these mechanisms can be therapeutically targeted.
References
- 1. Stockand JD et al.. 1997. Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease.. Am J Kidney Dis 29(6):971-81 PMID: 9186087
- 2. Li Y et al.. 2025. G-protein coupled receptor GPR124 protects against podocyte senescence and injury in diabetic kidney disease.. Kidney Int 107(4):652-665 PMID: 39828038
- 3. Bateman RM et al.. 2016. 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.. Crit Care 20(Suppl 2):94 PMID: 27885969
- 4. Zhang S et al.. 2025. GSTK1 and RETREG1/FAM134B-mediated reticulophagy attenuates tubular injury in diabetic nephropathy through endoplasmic reticulum stress and apoptosis.. Autophagy 21(12):2826-2841 PMID: 40778749
- 5. Prasad RM et al.. 2026. Microalbuminuria.. PMID: 33085402
- 7. Fan Y et al.. 2019. Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression.. Diabetes 68(12):2301-2314 PMID: 31578193
- 8. Romero CA et al.. 2019. Tubule-vascular feedback in renal autoregulation.. Am J Physiol Renal Physiol 316(6):F1218-F1226 PMID: 30838873
